ERAS
Erasca, Inc.NASDAQHealthcare$17.81+7.29%ClosedMarket Cap: $5.54B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
14.93
P/S
0.00
EV/EBITDA
-41.90
DCF Value
$0.10
FCF Yield
-1.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-34.5%
ROA
-31.4%
ROIC
-37.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-32.6M | $-29.1M | $-0.10 | — |
| FY 2025 | $0.00 | -Infinity% | $-131.4M | $-124.5M | $-0.44 | — |
| Q3 2025 | $0.00 | NaN% | $-34.5M | $-30.6M | $-0.11 | — |
| Q2 2025 | $0.00 | NaN% | $-38.1M | $-33.9M | $-0.12 | — |
| Q1 2025 | $0.00 | NaN% | $-35.6M | $-31.0M | $-0.11 | — |
| Q4 2024 | $0.00 | -Infinity% | $-35.7M | $-32.2M | $-0.11 | — |
| FY 2024 | $0.00 | NaN% | $-179.6M | $-161.7M | $-0.69 | — |
| Q3 2024 | $0.00 | NaN% | $-37.2M | $-31.2M | $-0.11 | — |
| Q2 2024 | $0.00 | NaN% | $-67.8M | $-63.2M | $-0.29 | — |
| Q1 2024 | $0.00 | -Infinity% | $-38.9M | $-35.0M | $-0.23 | — |
| Q4 2023 | $0.00 | -Infinity% | $-33.9M | $-29.7M | $-0.20 | — |
| FY 2023 | $0.00 | -Infinity% | $-141.5M | $-125.0M | $-0.83 | — |